Cargando…

The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer

BACKGROUND: This study aimed to explore the prognostic function of p53 and Ki-67 protein expression in chemotherapy sensitivity and prognosis in triple-negative breast cancer (TNBC). METHODS: Patients who were confirmed with TNBC in Wenzhou Geriatric Hospital and Wenzhou Hospital of Traditional Chin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guojing, Shi, Zhongyi, Liu, Lina, Yuan, Heqing, Pan, Zheng, Li, Wenxu, Tao, Yu, Huang, Zhaoming, Huang, Xiaoying, Lin, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798569/ https://www.ncbi.nlm.nih.gov/pubmed/35116435 http://dx.doi.org/10.21037/tcr-21-180

Ejemplares similares

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
por: Wang, Yihua, et al.
Publicado: (2021)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
por: Ameh-Mensah, Charity, et al.
Publicado: (2021)

Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers
por: Srivastava, Pooja, et al.
Publicado: (2022)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67
por: Kashiwagi, Shinichiro, et al.
Publicado: (2011)

KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance
por: Arafah, Maria A, et al.
Publicado: (2021)

New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer
por: Hao, Shuang, et al.
Publicado: (2016)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
por: Wu, Qiang, et al.
Publicado: (2019)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
por: Wang, Ruo-Xi, et al.
Publicado: (2016)

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
por: Huang, Liang, et al.
Publicado: (2013)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
por: Kitson, Sarah, et al.
Publicado: (2017)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin
por: Yan, Fengcai, et al.
Publicado: (2021)

Dimensional Analysis of CD44(High) CD24(Low) and Ki67 in Triple Negative Breast Cancer
por: Tan, Betty, et al.
Publicado: (2019)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
por: Nylander, Karin, et al.
Publicado: (1997)

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas
por: XIAO, LI-JUN, et al.
Publicado: (2013)

Coexistence of HER2, Ki67, and p53 in Osteosarcoma: A Strong Prognostic Factor
por: Mardanpour, Keykhosro, et al.
Publicado: (2016)

Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx
por: Rodrigues, Ricardo Boose, et al.
Publicado: (2015)

Analysis of the relationship between Ki-67 expression and chemotherapy and prognosis in advanced non-small cell lung cancer
por: Wang, Diming, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2hj7ivgj93denfao3k5ijl8i50